References
- Truscott B McN. Carcinoma of the breast. Br J Cancer 1947; 1: 129–32.
- Fisher B, Bauer M, Wickenham L, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551–7.
- Miller WR, Ellis JO, Sainsbury JRC, Dixon JM. ABC of breast disease. Prognostic factors. Br Med J 1994; 309: 1573–6.
- Hartveit F. Paranodal vascular spread in breast cancer with axillary node involvement. J Pathol 1979; 127: 111–4.
- Mwhle BO, Skjwrven R. Prediction of prognosis in axillary lymph node positive breast cancer patients: a statistical study. Br J Surg 1984; 71: 459–62.
- Hartveit F, Lilleng PK. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathol 1996; 28: 241–6.
- Hartveit F. The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol 1984; 143: 187–91.
- Lilleng PK, Hartveit F. Staging nodal growth in breast cancer on a histological basis. Eur J Gynaec Oncol 1997; 19: 249–52.
- SYSTAT for Windows, Version 9.0. Copyright C 1999 by SPSS.
- Bundred NJ, Morgan DAL, Dixon JM. Management of regional nodes in breast cancer. Br Med J 1994; 309: 1222–3.
- Goldstein NS, Mani A, Vicini F, Ingold J. Prognostic features in patients with stage Ti breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion. Am J Clin Pathol 1999; 1 1 1: 21–8.
- Fentiman IS, Mansel RE. The axilla: not a no go zone. Lancet 1991; 337: 221–3.
- Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 3: 394–401.
- Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818–22.
- Rodenhuis S, Richel DJ, Van de Wall E, et al. Randomised trial of high-dose chemotherapy and haemopoietic progeni-tor-cell support in operable breast cancer with extensive axil-lary lymph-node involvement. Lancet 1998; 352: 515–21.